Succinylcholine Chloride Injection shortage
Not a nationwide shortage — Fresenius Kabi has told the FDA it is discontinuing its succinylcholine chloride injections.
- The FDA lists this under “To be discontinued” as of Nov 21, 2026: a company stopping its own product.
- 11 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
- Status
- FDA term: “To Be Discontinued”
- Products on the record
- 1
- Category
- First posted
- Jul 23, 2026
- Last updated
- Jul 23, 2026
- Medicaid use (2026)
This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy
The Bottom Line
Fresenius Kabi is stopping its succinylcholine chloride injection, and this change may be permanent. The same 20 mg/mL medicine is still listed by other makers that have not reported a shortage, including Hikma and Hospira.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Is Succinylcholine Chloride Being Discontinued? Status as of Nov 21, 2026
Not as a whole, as of Nov 21, 2026. Fresenius Kabi is stopping its own version only; 11 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.
The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.
Availability of the Affected Products
From the FDA shortage report: 1 product
Is Every Strength Still Made?
A medicine often comes in several strengths, and more than one company may make each. This shows whether at least one company still makes each strength on the record: a company on the shortage report that still has supply, or another company that sells it.
1 of 1 strength
- 20 mg/mLStill made by a company
Other Companies Listing the Same Medicine, Not Reporting a Shortage
Companies that list Succinylcholine Chloride Injection with the FDA and have not reported a shortage (not counted in the charts above).
- Hikma Pharmaceuticals USA Inc.
- Hospira, Inc.
- Camber Pharmaceuticals, Inc.
- Dr.Reddy's Laboratories Inc.,
- Piramal Critical Care Inc
- Nordic Pharma, Inc.
- Somerset Therapeutics, LLC
- REMEDYREPACK INC.
- Zydus Pharmaceuticals USA Inc.
- Meitheal Pharmaceuticals Inc.
- Devatis, Inc.
Shortage Timeline
- Jul 23, 2026 Discontinuation notice on file 1 of 1 product affected.
- Jul 23, 2026 First reported to the FDA 1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
Which Succinylcholine Chloride Products Are Affected, by Company
Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get succinylcholine chloride?).
Company: Fresenius Kabi USA, LLC
-
Succinylcholine Chloride Injection, 20 mg/mL
- Strength
- 20 mg/mL
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
Why Is Fresenius Kabi Discontinuing Succinylcholine Chloride?
A note from Dr. Brian Staiger, PharmD · Written Oct 8, 2026
Succinylcholine chloride injection is on the FDA list because Fresenius Kabi USA has told the FDA it is discontinuing it. The FDA status is "To Be Discontinued," which means the company plans to stop making this product.
The specific product affected is the 20 mg/1 mL injection (NDC 63323-943-10). The company's note says only "discontinuation of the manufacture of the drug." No separate reason code was given, and the company did not share a public explanation for why it is stopping. The report also doesn't include any dates for when supply might run out, and it doesn't list any strength or package size that will keep being made.
This report covers only Fresenius Kabi's product. It doesn't tell us what other companies are doing with this medicine.
What Should I Do If I Take Succinylcholine Chloride?
A note from Dr. Brian Staiger, PharmD · Written Oct 8, 2026
Succinylcholine Chloride Injection is currently on the FDA drug-shortage list, but the overall supply risk is rated low (1 out of 5).
This medicine comes in one strength, 20 mg/mL. The company that filed this report, Fresenius Kabi USA, has no supply of its 20 mg/mL product. However, the same 20 mg/mL strength is still listed by several other companies that have not reported a shortage.
The reason given is that Fresenius Kabi is stopping production of this drug. Because its product is marked "to be discontinued," this supply gap may be permanent for that maker. That does not mean the medicine is gone. Other makers, such as Hikma, Hospira (sold as Quelicin), Zydus, and Meitheal, list the same medicine in the same strength.
Here is what you can do:
- Do not stop, skip, or change any dose on your own.
- Ask your pharmacy or care team whether they can get the same medicine from another maker. Pharmacies can check wholesalers, but it may not be in local stock.
- If it cannot be found, talk with your prescriber or pharmacist about options, such as an alternative they choose for you.
- The manufacturer's contact number is listed on this page for reference. Pharmacies usually handle these calls.
This information comes from national, manufacturer-reported FDA data. It may not match what your local pharmacy has on hand, and it is not personal medical advice.
Quick checklist for the pharmacy counter
- Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
- If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.
Where Else Can I Get Succinylcholine Chloride?
From the current FDA NDC Directory: the same medicine from companies that have not reported a shortage.
- Some listings are repackagers, which relabel another company’s product.
- A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same Medicine From Other Companies (Not Reporting a Shortage)
The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.
| Product | Strength | Form / route | Company | NDC |
|---|---|---|---|---|
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 00143-9338-25 |
| Quelicin | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Hospira, Inc. | 00409-6629-02 |
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Camber Pharmaceuticals, Inc. | 31722-0981-31 |
| Succinylcholine | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Dr.Reddy's Laboratories Inc., | 43598-0666-25 |
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Piramal Critical Care Inc | 66794-0232-42 |
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Nordic Pharma, Inc. | 69918-0700-10 |
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Somerset Therapeutics, LLC | 70069-0301-10 |
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | REMEDYREPACK INC. | 70518-4409-00 |
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Zydus Pharmaceuticals USA Inc. | 70710-1377-02 |
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Meitheal Pharmaceuticals Inc. | 71288-0719-11 |
| Succinylcholine Chloride | 20 mg/mL | Injection, Solution · Intramuscular, Intravenous | Devatis, Inc. | 73043-0021-01 |
Therapeutic Equivalents and Pricing 30 products
Other products the FDA rates as interchangeable with the affected strengths, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.
| Product | Manufacturer | Package | Pharmacy cost per unit (NADAC) | FDA rated equivalent | Availability |
|---|---|---|---|---|---|
| Succinylcholine Chloride 20 mg/mLNDC 00143-9338-25 | Hikma | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 00404-9983-20 | Henry | 1 vial | — | AP | FDA listed |
| Quelicin 20 mg/mLNDC 00409-6629-02 | Hospira, | 25 vials | — | AP | FDA listed |
| Anectine 20 mg/mLNDC 00781-3411-95 | Sandoz | 10 vials | — | AP | FDA listed |
| Anectine 20 mg/mLNDC 00781-9053-95 | Sandoz | 10 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 14445-0407-25 | Indoco | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 31722-0981-31 | Camber | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 200 mg/10mLNDC 42571-0371-87 | Micro | 25 vials | — | AP | FDA listed |
| Succinylcholine 20 mg/mLNDC 43598-0666-25 | Dr.Reddy's | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 51662-1525-01 | HF | 10 ml | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 55150-0315-25 | Eugia | 25 vials | — | — | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 63323-0943-10 | Fresenius | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 66794-0232-42 | Piramal | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 68083-0450-25 | Gland | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 69918-0700-11 | Nordic | 10 vials | — | AP | Discontinued |
| Succinylcholine Chloride 20 mg/mLNDC 70069-0301-25 | Somerset | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 70069-0783-10 | Somerset | 10 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 70121-1581-05 | Amneal | 25 vials | — | — | Discontinued |
| Succinylcholine Chloride 20 mg/mLNDC 70518-4409-00 | REMEDYREPACK | 10 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 70710-1377-02 | Zydus | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 70756-0613-10 | Lifestar | 10 vials | — | — | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 70771-1352-07 | Zydus | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 71288-0719-11 | Meitheal | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 71839-0121-25 | BE | 25 vials | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 71872-7166-01 | Medical | 1 vial | — | — | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 71872-7167-01 | Medical | 1 vial | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 71872-7221-01 | Medical | 1 vial | — | AP | FDA listed |
| Succinylcholine 20 mg/mLNDC 71872-7241-01 | Medical | 1 vial | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 71872-7272-01 | Medical | 1 vial | — | AP | FDA listed |
| Succinylcholine Chloride 20 mg/mLNDC 71872-7275-01 | Medical | 1 vial | — | AP | FDA listed |
These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.
Other Drugs in the Same Treatment Class
These are different medicines — not other versions of succinylcholine chloride — that fall in the same broad treatment class (neuromuscular blocking agents). They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Codes & Classification for pharmacists and billers
- GCN Seq No
- 004676
- GCN
- 17992
- HICL code
- 001948
- Ingredient (HICL)
- Succinylcholine Chloride
- HIC1 code
- S
- Therapeutic class — broad (HIC1)
- Locomotor System
- HIC2 code
- S7
- Therapeutic class — intermediate (HIC2)
- Affect Primarily Skeletal Muscle
- HIC3 code
- S7A
- Therapeutic class — specific (HIC3)
- Neuromuscular Blocking Agents
- AHFS code
- 12:20.20.00
- AHFS class
- Neuromuscular Blocking Agents
- FDB label name
- SUCCINYLCHOLINE 200 MG/10 ML
- FDB brand name
- Succinylcholine Chloride
- Legend status
- F — Federal legend — prescription drug or device
- GPI-14
- 74100010102005
- GPI class
- Succinylcholine Chloride
Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.
Other Anesthesia Shortages
- Glycopyrrolate InjectionA company is discontinuing its version · 4 products
- Desflurane for InhalationA company is discontinuing its version · 1 product
- Rocuronium Bromide InjectionIn shortage · 26 products
- Etomidate Injection (Amidate)In shortage · 18 products
- Dexmedetomidine Hydrochloride Injection (Precedex)In shortage · 58 products
- Ropivacaine Hydrochloride Injection (Naropin)In shortage · 49 products
- Bupivacaine Hydrochloride Injection (Marcaine, Sensorcaine)In shortage · 55 products
- Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (Marcaine with Epinephrine, Sensorcaine)In shortage · 26 products
Succinylcholine chloride Shortage FAQs
Is succinylcholine chloride discontinued?
Only Fresenius Kabi’s version. Fresenius Kabi has told the FDA it is stopping its own product (listed under “To be discontinued” as of Nov 21, 2026), while 11 other companies still sell the same medicine and have not reported a problem (Hikma Pharmaceuticals, Hospira, Camber Pharmaceuticals and 8 more). It is not a nationwide shortage.
Which strengths of succinylcholine chloride are affected?
The FDA record covers 1 strength: 20 mg/mL. Every strength on the record is still made by at least one company, though stock varies by pharmacy.
Which succinylcholine chloride products are affected?
Succinylcholine Chloride Injection, 20 mg/mL (NDC 63323-0943-10). The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.
When will succinylcholine chloride be available again?
A discontinuation is usually permanent for that company’s product. The same medicine is still sold by Hikma Pharmaceuticals, Hospira, Camber Pharmaceuticals and 8 more, so ask your pharmacy to order another company’s version.
Can I still get succinylcholine chloride somewhere?
Other companies (Hikma Pharmaceuticals, Hospira, Camber Pharmaceuticals and 8 more) sell the same medicine and have not reported a problem. See “Where else can I get succinylcholine chloride?” above — stock still varies by pharmacy.
What should I do if I take succinylcholine chloride?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.
How to Read the Supply-Risk Rating
Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.
- Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Succinylcholine chloride is rated Low: 0 of 5 risk factors.
- Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
- High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.
Back to this drug’s rating ↑ · How we rate supply risk, in full
Where This Data Comes From
- The FDA’s drug shortage database, checked every day: the companies, their products and the codes on their boxes (NDCs), the status, the reason and the dates. See the FDA’s record for this shortage ↗
- The FDA’s NDC Directory: the other companies that make the same medicine, which the supply-risk rating counts.
- CMS Medicaid prescription data: how widely it is used. It counts Medicaid prescriptions only, so it is a rough guide, not total U.S. use.
- First Databank and CMS NADAC: matching the same medicine across companies, and what pharmacies pay for the equivalents.
For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.